As you might assume, the SSO was educational. But it was also no fun. No fun at all. That’s why we all look so unhappy. 🤣🎉🥳 #SSO2024 Society of Surgical Oncology #fundraiser #partytime #CancerAwareness

Happy #SSO2024

let’s do this 👊🏼💥🤩 #SSO2024

Our fellows presented their work #SSO2024

Catherine Sarre on their review of #sarcoma care in Mexico 🇲🇽
Many opportunities for collaborative work ahead

🎥 Netflix category: Strong Black Lead 😍 #StrivingForInclusiveExcellence #SSO2024

Superb presentation by ⁦Emilie Warren⁩ on Novel Target for Cholangiocarcinoma - Gal-9. ⁦Emory Surgery⁩ ⁦Winship Cancer Institute of Emory University⁩ ⁦Emory School of Medicine⁩ ⁦Society of Surgical Oncology⁩ Shishir K. Maithel⁩ ⁦Gregory Lesinski⁩ #SSO2024
🔬to 🩺 ✅

Solid review on #CRS /HIPEC by ⁦Maria Russell⁩ ⁦Emory Surgery⁩ ⁦Winship Cancer Institute of Emory University⁩ ⁦Society of Surgical Oncology⁩
Moderated by ⁦Alexandra Gangi, MD⁩ ⁦Jeremiah Deneve⁩
#SSO2024

#SSO2024 oh what a night! Raising money 💰 and the roof for cancer ♋️ research 🔬! Society of Surgical Oncology UChicago Surgery UChicago Surgery Residents Endeavor Health

Repping ⁦RAS-ACS⁩ at the ⁦Society of Surgical Oncology⁩ meeting! #SSO2024 ⁦LaDonna Kearse, MD⁩

Our fellows presented their work #SSO2024

Gabriela Alejandra Buerba on their work on omitting ALND with positive SLNB post neoadjuvant therapy
📈No difference in DFS or OS for completion ALND vs not
Sunnybrook Health Sciences Centre Frances Wright Society of Surgical Oncology

All stage IV disease is not the same as Jennifer Plichta MD (she/her) demonstrated, but can be stratified into 4 distinct subgroups. International validation of her prior work from NCDB. 3 year survival varies from 27% to 83% based on subgroup. Will this be added to AJCC 9th edition? #SSO2024

G8 presentation by Daniel Knewitz on our HILP experience and how it still has a role in #melanoma in era of effective immunotherapy(IO). Response rates very high for in-transit dz. IO prior to HILP improves DFS, OS. Pts who progressed or failed IO, HILP still effective #SSO2024

#beardedmen #SSO2024 great to see Flavio G Rocha, MD, FACS, FSSO

UT Southwestern Division of Surgical Oncology faculty, fellows, research residents & friends celebrating a highly successful presence on the program at #SSO2024 . Kudos to Division Chief Adam Yopp! ⁦UTSW Surgery⁩ ⁦UTSW Simmons Cancer Center⁩ ⁦@UTSWNews⁩

We are still so energized after an amazing #SSO2024 and we hope you are too! Enjoy this recap of some of our favorite moments. Leave a comment 👇with your favorite moments, sessions, or speakers so we can continue to be the premier meeting in surgical oncology for years to come!

Our Mayo Clinic AZ Department of Surgery Division of Surgical Oncology had a phenomenal presence at #SSO2024 Society of Surgical Oncology in Atlanta.

👇🏻Chee-Chee Stucky moderating, Kavin Sugumar, MD Zhi Ven Fong, MD MPH DrPH delivering oral presentation, #NabilWasif delivering plenary& Akash Kartik winning best resident abstract award!

Wrapping up a wonderful #SSO2024 meeting with equally wonderful T32 surgical oncology research co-fellows Neha Malik MD Brittany C. Fields, MD, MPH Robin Wright and T32 PD Ashley Holder, MD.

Thank you MD Anderson Cancer Center for bringing us together. Missing Sophia Williams-Perez, MD and Anish Jay Jain MD! Society of Surgical Oncology

Honored to receive the ⁦Society of Surgical Oncology⁩ Clinical Investigator Award! Thankful for my incredible research team, mentors, and patients. ⁦Sylvester Comprehensive Cancer Center⁩ ⁦Nipun Merchant⁩ ⁦Susan Beth Kesmodel⁩ ⁦Erin Kobetz⁩ ⁦Stephen D. Nimer, MD⁩ ⁦Alexandra Hernandez, MD, MPH⁩ #SSO2024

1st (of many) Society for Immunotherapy of Cancer meetings partnered with Society of Surgical Oncology annual meeting. Great presentations and discussions lead by Genevieve Boland, MD, PhD MarkFariesMD Stephanie Downs-Canner and Simon Tuecotte
#SSO2024

Dr. Tracey Pu did an amazing job conveying HUGE amounts of data that impressively identifies a new target AND drug candidates for NETs #SSO2024